Young R C, Anderson T, DeVita V T
Curr Probl Cancer. 1977 Jan;1(7):1-29. doi: 10.1016/s0147-0272(77)80009-3.
During the past 10--15 years there has been a dramatic improvement in the prognosis of patients with Hodgkin's diases. More than 80% of all patients now will live 5+ years, many of them free from disease. The well-recognized immediate complications of therapy discussed above, are insignificant compared to the tremendous improvement in patients' survival. The fact that they now probably will survive long enough to potentially be at risk of such long-term complications is a testament to the efficacy of modern-day aggressive therapy.
在过去的10至15年里，霍奇金病患者的预后有了显著改善。现在超过80%的患者能存活5年以上，其中许多人无病生存。与患者生存率的巨大提高相比，上述公认的治疗即时并发症微不足道。他们现在很可能存活足够长的时间，从而有可能面临此类长期并发症的风险，这证明了现代积极治疗的有效性。
